跳到主要內容

Ryan Arthur F 的 Form 4 申報

Regeneron Pharmaceuticals, Inc.(REGN),2024/3/5 申報

申報編號
0001968202-24-000084
申報時間
2024/3/5
交易日
2024/3/1
申報延遲
4 天
10b5-1 計畫
有勾選

這份申報列了 21 筆非衍生性交易。公開市場賣出合計 $9.82 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Ryan Arthur FCIK 0001187443董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2024/3/1Common StockS賣出處分−1$967.50−$967.518,381直接
2024/3/1Common StockS賣出處分−1$968.66−$968.6618,380直接
2024/3/1Common StockS賣出處分−1$969.18−$969.1818,379直接
2024/3/1Common StockS賣出處分−4$970.38−$3,881.5218,375直接
2024/3/1Common StockS賣出處分−1$971.75−$971.7518,374直接
2024/3/1Common StockS賣出處分−2$972.29−$1,944.5818,372直接
2024/3/1Common StockS賣出處分−1$974.78−$974.7818,371直接
2024/3/1Common StockS賣出處分−2$975.70−$1,951.418,369直接
2024/3/1Common StockS賣出處分−2$976.81−$1,953.6218,367直接
2024/3/1Common StockS賣出處分−2$977.27F2−$1,954.5418,365直接
2024/3/1Common StockS賣出處分−1$978.09−$978.0918,364直接
2024/3/1Common StockS賣出處分−1$979.87−$979.8718,363直接
2024/3/1Common StockS賣出處分−1$980.21−$980.2118,362直接
2024/3/1Common StockS賣出處分−15$981.64F3−$14,724.618,347直接
2024/3/1Common StockS賣出處分−11$982.67F4−$10,809.3718,336直接
2024/3/1Common StockS賣出處分−12$983.61F5−$11,803.3218,324直接
2024/3/1Common StockS賣出處分−19$984.45F6−$18,704.5518,305直接
2024/3/1Common StockS賣出處分−10$985.76F7−$9,857.618,295直接
2024/3/1Common StockS賣出處分−8$986.58F8−$7,892.6418,287直接
2024/3/1Common StockS賣出處分−4$987.33F9−$3,949.3218,283直接
2024/3/1Common StockS賣出處分−1$988.30−$988.318,282直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

Represents volume-weighted average price of sales of 2 shares of Company stock on March 1, 2024 at prices ranging from $977.00 to $977.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F3

Represents volume-weighted average price of sales of 15 shares of Company stock on March 1, 2024 at prices ranging from $981.09 to $981.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F4

Represents volume-weighted average price of sales of 11 shares of Company stock on March 1, 2024 at prices ranging from $982.51 to $982.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F5

Represents volume-weighted average price of sales of 12 shares of Company stock on March 1, 2024 at prices ranging from $983.21 to $983.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F6

Represents volume-weighted average price of sales of 19 shares of Company stock on March 1, 2024 at prices ranging from $984.00 to $984.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F7

Represents volume-weighted average price of sales of 10 shares of Company stock on March 1, 2024 at prices ranging from $985.26 to $985.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F8

Represents volume-weighted average price of sales of 8 shares of Company stock on March 1, 2024 at prices ranging from $986.45 to $986.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F9

Represents volume-weighted average price of sales of 4 shares of Company stock on March 1, 2024 at prices ranging from $987.05 to $987.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)